340 related articles for article (PubMed ID: 17426002)
1. [Therapeutic efficacy of strontium-89-chloride for bone metastatic tumors without bone pain].
Ouyang W; Liu JH; Liu WY
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):390-1. PubMed ID: 17426002
[TBL] [Abstract][Full Text] [Related]
2. [Strontium-89: a desirable therapeutic for bone metastases of prostate cancer].
Ma YB; Yan WL; Dai JC; Xu F; Yuan Q; Shi HH
Zhonghua Nan Ke Xue; 2008 Sep; 14(9):819-22. PubMed ID: 18998467
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic effects of strontium-89 against osseous metastases of lung cancer: analysis of 126 cases].
Zheng H; Luo RC; Fan YX
Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1194-6. PubMed ID: 15485798
[TBL] [Abstract][Full Text] [Related]
4. Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases.
Storto G; Klain M; Paone G; Liuzzi R; Molino L; Marinelli A; Soricelli A; Pace L; Salvatore M
Bone; 2006 Jul; 39(1):35-41. PubMed ID: 16434248
[TBL] [Abstract][Full Text] [Related]
5. Bone pain palliation with 85Sr therapy.
Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
[TBL] [Abstract][Full Text] [Related]
6. [89SrCl2 in the treatment of cancer patients with bone metastasis and pain].
Sun D; Chu Y; Lou C; Wang QJ; Zhan HW; He GQ
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):499-501. PubMed ID: 16188153
[TBL] [Abstract][Full Text] [Related]
7. [Internal strontium-89 radiotherapy for malignant bony metastasis].
Lou C; Zhang D; Yu L
Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):507-9. PubMed ID: 11859724
[TBL] [Abstract][Full Text] [Related]
8. Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma.
Breen SL; Powe JE; Porter AT
J Nucl Med; 1992 Jul; 33(7):1316-23. PubMed ID: 1613572
[TBL] [Abstract][Full Text] [Related]
9. Radionuclide-targeted therapy for the management of metastatic bone pain.
Ackery D; Yardley J
Semin Oncol; 1993 Jun; 20(3 Suppl 2):27-31. PubMed ID: 7684862
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of IL-2 and TNF-alpha in patients with painful bone metastases: correlation with responses to 89SrCl2 therapy.
Fang N; Li Y; Xu YS; Ma D; Fu P; Gao HQ; Gao FT; Yang HS; Yang ZJ
J Nucl Med; 2006 Feb; 47(2):242-6. PubMed ID: 16455629
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma.
Papatheofanis FJ
J Nucl Med; 1997 Aug; 38(8):1175-9. PubMed ID: 9255144
[TBL] [Abstract][Full Text] [Related]
12. Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial.
Sciuto R; Festa A; Rea S; Pasqualoni R; Bergomi S; Petrilli G; Maini CL
J Nucl Med; 2002 Jan; 43(1):79-86. PubMed ID: 11801708
[TBL] [Abstract][Full Text] [Related]
13. Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy.
Tu SM; Kim J; Pagliaro LC; Vakar-Lopez F; Wong FC; Wen S; General R; Podoloff DA; Lin SH; Logothetis CJ
J Clin Oncol; 2005 Nov; 23(31):7904-10. PubMed ID: 16258090
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary application of strontium-89 for the treatment of bone metastases from prostate cancer].
Zhao W; Deng H; Jie P; Qing C; Zhang X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Dec; 27(6):1251-4. PubMed ID: 21374974
[TBL] [Abstract][Full Text] [Related]
15. Strontium-89 therapy for painful osseous metastatic prostate and breast cancer.
Hansen DV; Holmes ER; Catton G; Thorne DA; Chadwick DH; Schmutz DA
Am Fam Physician; 1993 Jun; 47(8):1795-800. PubMed ID: 7684554
[TBL] [Abstract][Full Text] [Related]
16. [Possibilities of systemic radiotherapy with high-purity 89Sr chloride in the treatment of bone metastases].
Fomin DK; Tararukhina OB; Nazarov AA
Vestn Rentgenol Radiol; 2012; (2):29-31. PubMed ID: 22730757
[TBL] [Abstract][Full Text] [Related]
17. [The efficacy of therapy using 89Sr-strontium chloride in 200 patients with bone metastases of a prostatic cancer].
Haesner M; Buchali K; Pink V; Lips H
Nuklearmedizin; 1992 Mar; 31(2):48-52. PubMed ID: 1373485
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of strontium-89 palliative therapy in patients with painful bone metastases.
Zorga P; Birkenfeld B; Listewnik MH; Piwowarska-Bilska H
Ann Acad Med Stetin; 2011; 57(1):49-53; discussion 53. PubMed ID: 22593991
[TBL] [Abstract][Full Text] [Related]
19. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
Minutoli F; Herberg A; Spadaro P; Restifo Pecorella G; Baldari S; Aricò D; Altavilla G; Baldari S
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience with strontium-89 in prostatic and breast cancer patients.
Robinson RG; Preston DF; Baxter KG; Dusing RW; Spicer JA
Semin Oncol; 1993 Jun; 20(3 Suppl 2):44-8. PubMed ID: 8503027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
